As of 2025-12-17, the EV/EBITDA ratio of Proteome Sciences PLC (PRM.L) is -16.16. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PRM.L's latest enterprise value is 23.40 mil GBP. PRM.L's TTM EBITDA according to its financial statements is -1.45 mil GBP. Dividing these 2 quantities gives us the above PRM.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.1x - 20.0x | 17.2x |
| Forward P/E multiples | 10.3x - 18.2x | 14.2x |
| Fair Price | (9.14) - (11.59) | (10.57) |
| Upside | -495.7% - -601.6% | -557.7% |
| Date | EV/EBITDA |
| 2025-12-12 | -16.32 |
| 2025-12-11 | -16.30 |
| 2025-12-10 | -16.30 |
| 2025-12-09 | -16.45 |
| 2025-12-08 | -16.37 |
| 2025-12-05 | -17.04 |
| 2025-12-04 | -17.38 |
| 2025-12-03 | -16.03 |
| 2025-12-02 | -14.60 |
| 2025-12-01 | -14.61 |
| 2025-11-28 | -10.49 |
| 2025-11-27 | -10.49 |
| 2025-11-26 | -10.49 |
| 2025-11-25 | -10.49 |
| 2025-11-24 | -10.49 |
| 2025-11-21 | -10.49 |
| 2025-11-20 | -10.49 |
| 2025-11-19 | -10.49 |
| 2025-11-18 | -10.49 |
| 2025-11-17 | -10.49 |
| 2025-11-14 | -10.49 |
| 2025-11-13 | -10.49 |
| 2025-11-12 | -10.49 |
| 2025-11-11 | -10.49 |
| 2025-11-10 | -10.49 |
| 2025-11-07 | -10.49 |
| 2025-11-06 | -10.49 |
| 2025-11-05 | -14.58 |
| 2025-11-04 | -14.58 |
| 2025-11-03 | -15.42 |
| 2025-10-31 | -15.42 |
| 2025-10-30 | -15.42 |
| 2025-10-29 | -15.42 |
| 2025-10-28 | -15.42 |
| 2025-10-27 | -15.42 |
| 2025-10-24 | -10.50 |
| 2025-10-23 | -10.50 |
| 2025-10-22 | -15.42 |
| 2025-10-21 | -15.42 |
| 2025-10-20 | -15.36 |
| 2025-10-17 | -14.35 |
| 2025-10-16 | -15.27 |
| 2025-10-15 | -15.30 |
| 2025-10-14 | -15.25 |
| 2025-10-13 | -15.15 |
| 2025-10-10 | -15.65 |
| 2025-10-09 | -14.97 |
| 2025-10-08 | -15.05 |
| 2025-10-07 | -14.84 |
| 2025-10-06 | -15.30 |